Subsequently, the WST-1 and wound-healing assays revealed that the specific suppression of MCC translation significantly increased the proliferation and migration of siRNA-treated cells compared with control cells (Figures 5B, C), suggesting that MCC might act as an anti-tumor agent in glioblastoma. This evidence concerns the gene MCC and glioblastoma.